Matters of the heart: A scoping review toward better management of nontuberculous mycobacterial infections of cardiac devices [0.03%]
心事重重：面向更好管理心脏设备的非结核分枝杆菌感染的范围审查
Rattanaporn Mahatanan,Maria Alkozah,Devin Lee et al.
Rattanaporn Mahatanan et al.
Background: Implantable cardiac device-related (ICDR) nontuberculous mycobacteria (NTM) infections are increasingly reported in the literature, but guidelines for optimal management are lacking. ...
Strengthening the global Response to Tuberculosis: Insights from the 2024 WHO global TB report [0.03%]
强化全球结核病应对：2024年世卫组织全球结核病报告的启示
Fatemeh Estaji,Ali Kamali,Masoud Keikha
Fatemeh Estaji
Detection of extensive drug resistance by the Xpert MTB/XDR assay in multidrug resistant tuberculosis cases at a tertiary care centre in northern India, and therapeutic decision making for the six-month BPaLM regimen [0.03%]
印度北部一家三级护理中心耐多药结核病患者XpertMTB/XDR检测广泛耐药的阳性结果及六月疗程BPaLM方案的治疗决策研究
Richa Misra,Parijat Das,Alok Nath et al.
Richa Misra et al.
The Xpert MTB/XDR assay has been approved by World Health Organization (WHO) as a reflex test on sputum samples after testing for rifampicin resistance. Recently, the Union Health Ministry of India in September 2024 approved the introductio...
Cost effectiveness analysis of expanding tuberculosis preventive therapy to household contacts aged 5-14 years in the Philippines [0.03%]
菲律宾扩大结核病预防治疗至5-14岁家庭接触者的成本效益分析
Ghassan Ilaiwy,Jessica Keim-Malpass,Romella Tuppal et al.
Ghassan Ilaiwy et al.
Background: Children aged 5-14 years who are household contacts (HHCs) of index people with active TB disease (PWTB) have limited coverage for TB preventive therapy (TPT) due to variable uptake of the national guideline r...
Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European setting [0.03%]
东欧地区标准TB-феронFIA和标准TB-feron酶联免疫吸附试验检测结核感染的诊断准确性研究
Valeriu Crudu,Dumitru Chesov,Alexandru Codreanu et al.
Valeriu Crudu et al.
Introduction: Tuberculosis infection (TBI) is diagnosed based on a positive immune response to M. tuberculosis antigens. This study aimed to evaluate both the qualitative and quantitative performance of two novel IGRA-bas...
Adverse drug reactions and contributing factors in patients with drug-resistant tuberculosis: A 7-year retrospective cohort study in Addis Ababa, Ethiopia [0.03%]
药物 resistant 结核病患者的药物不良反应及影响因素：来自埃塞俄比亚 Addis Ababa 的一项为期七年的回顾性队列研究
Bisrat Solomon,Yimtubezinash Woldeamanuel,Tigest Ajeme et al.
Bisrat Solomon et al.
Background: Drug-resistant tuberculosis poses a major global public health threat, with adverse drug reactions complicating treatment and contributing to mortality. In Ethiopia, although many patients with drug-resistant ...
Machine learning analysis for predicting acid-fast bacilli results in tuberculosis sputum tests: Comment [0.03%]
用于预测结核病痰涂片抗酸杆菌结果的机器学习分析：评论
Hinpetch Daungsupawong,Viroj Wiwanitkit
Hinpetch Daungsupawong
Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease [0.03%]
实现鸟分枝杆菌复合体肺病指南推荐的阿米卡星水平的挑战
Takuya Akutsu,Kazuya Tone,Airi Hasegawa et al.
Takuya Akutsu et al.
Background: The addition of aminoglycosides to a macrolide-based regimen is recommended for refractory Mycobacterium avium complex pulmonary disease (MAC-PD). For intravenous amikacin (AMK) administration three times a we...
Maximizing tuberculosis services through private provider engagement - A case study from Pakistan [0.03%]
通过使私人医疗机构参与来提高结核病服务质量 —— 来自巴基斯坦的一个实例研究
Aamna Rashid,Surbhi Sheokand,Razia Fatima et al.
Aamna Rashid et al.
Pakistan is the fourth highest contributor to the globally estimated 3.7 million tuberculosis (TB) cases. Due to the subpar condition of public sector facilities in Pakistan, the private sector remains the preferred choice, with over 90% of...
Corrigendum to "Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018-2021" [J. Clin. Tuberc. Other Mycobact. Dis. 36 (2024) 100460] [0.03%]
《生物药物患者的结核病筛查：纽约州蒙罗县2018-2021年单中心经验和学会指南回顾》[J. Clin. Tuberc. Other Mycobact. Dis. 36 (2024) 100460]的勘误表
Tetsuro Maeda,Margaret Connolly,Kelly Thevenet-Morrison et al.
Tetsuro Maeda et al.
[This corrects the article DOI: 10.1016/j.jctube.2024.100460.]. © 2024 The Author(s).